Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer [Phase 1, Phase 2]
Clinical trial update on radiation therapy with combination chemotherapy for stage II/III bladder cancer, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 clinical trial of rucaparib in locally advanced or metastatic urothelial carcinoma was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function [Phase 2]
Phase 2 trial evaluating a combination of gemcitabine, paclitaxel, and doxorubicin in metastatic or unresectable bladder cancer with decreas…
-
FDA approval · 2020-10-06FDA Approved: GEMCITABINE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for gemcitabine from Fresenius Kabi USA, approving a generic gemcitabine product under ANDA 090799. …
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Perioperative Analgesic Efficiency of Quadratus Lumborum Block vs Epidural in Radical Cystectomy [Phase 2]
Phase 2 trial comparing quadratus lumborum block to epidural for perioperative analgesia in radical cystectomy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer [Phase 2]
Phase 2 clinical trial evaluating erlotinib hydrochloride in patients with muscle-invasive or recurrent urothelial cancer has completed, wit…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Tranexamic Acid Infusion in Low Dose Versus in High Dose for Reducing Blood Loss in Radical Cystectomy Operations [Phase 4]
Phase 4 trial evaluating low-dose versus high-dose tranexamic acid infusion to reduce blood loss during radical cystectomy.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial of avelumab in non-metastatic muscle-invasive bladder cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer [Phase 2]
Phase 2 trial evaluating erlotinib combined with Green Tea Extract (Polyphenon E) for preventing cancer recurrence after bladder cancer surg…
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Propranolol Adjuvant Treatment of Bladder Cancer [Phase 2]
Phase 2 trial update on propranolol as adjuvant treatment for bladder cancer is in early-stage development with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Evaluation of Naloxegol in the Prevention of POI After Cystectomy [Phase 2]
Phase 2 clinical trial evaluating naloxegol for preventing postoperative ileus after cystectomy.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery [Phase 2]
Phase 2 clinical trial of erlotinib hydrochloride in bladder cancer patients undergoing surgery was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders [Phase 4]
Phase 4 clinical trial evaluating mebeverine for daytime and nocturnal incontinence after orthotopic ileal neobladders; completed.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Study of Tumour Focused Radiotherapy for Bladder Cancer [Phase 2]
Phase 2 clinical trial update on tumour-focused radiotherapy for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ [Phase 2]
Phase 2 clinical trial update for Vicinium in non-invasive urothelial carcinoma in situ of the bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. [Phase 3]
Phase 3 clinical trial investigating mitomycin C intravesical chemotherapy with Synergo radiofrequency-induced hyperthermia for Bacillus Cal…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB) [Phase 2]
Phase 2 trial evaluating durvalumab plus olaparib given before surgery in resectable bladder cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer [Phase 2]
A Phase 2 clinical trial update exploring chemotherapy as an alternative to surgery for low-risk bladder cancer.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Randomized Trial Comparing Robotic and Open Radical Cystectomy [Phase 3]
A Phase 3 randomized trial comparing robotic versus open radical cystectomy in bladder cancer has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients [Phase 1, Phase 2]
Phase I/II study of enadenotucirev given via sub-acute fractionated IV dosing in cancer patients (completed).
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT [Phase 1, Phase 2]
Phase 1/2 trial of HS-410 in non-muscle invasive bladder cancer was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 [Phase 2]
Phase 2 trial evaluating imaging of T-cell activation using [18F]F-AraG in urothelial carcinoma patients receiving neoadjuvant therapy or an…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial [NA]
A randomized trial comparing open versus robotic-assisted radical cystectomy for bladder cancer requiring cystectomy has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer [Phase 2]
Phase 2 trial evaluating oxaliplatin and gemcitabine in metastatic bladder cancer (carcinoma, transitional cell); study terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with INCB024360 in various selected cancers; study completed with results …